203 related articles for article (PubMed ID: 37796226)
21. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
24. Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes.
Zhang A; Jin Y; Zou X; Zhang S
Medicine (Baltimore); 2023 Jul; 102(28):e34275. PubMed ID: 37443469
[TBL] [Abstract][Full Text] [Related]
25.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
26. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
[TBL] [Abstract][Full Text] [Related]
27. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
28. A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma.
Huan C; Gao J
Math Biosci Eng; 2022 Aug; 19(12):12127-12145. PubMed ID: 36653989
[TBL] [Abstract][Full Text] [Related]
29. Identification of Exosome-Related Genes Associated with Prognosis and Immune Infiltration Features in Head-Neck Squamous Cell Carcinoma.
You Y; Du Z; Xu G; Tian Z; Xiao M; Wang Y
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371537
[TBL] [Abstract][Full Text] [Related]
30. Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
Meng D; Liu T; Ma F; Wang M
Medicine (Baltimore); 2021 Jan; 100(4):e24184. PubMed ID: 33530209
[TBL] [Abstract][Full Text] [Related]
31. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity.
Chi H; Yang J; Peng G; Zhang J; Song G; Xie X; Xia Z; Liu J; Tian G
Front Immunol; 2023; 14():1091218. PubMed ID: 36969232
[TBL] [Abstract][Full Text] [Related]
32. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
34. Dickkopf-1 is an immune infiltration-related prognostic biomarker of head and neck squamous cell carcinoma.
Zhao C; Liu L; He Q; Li Y; Feng J; Chen Y; Li Y; Xu X; Zhu S; Ye Y; Wen Y; Zeng Z; Zhou D; Jin F
Aging (Albany NY); 2024 Feb; 16(4):3837-3855. PubMed ID: 38376441
[TBL] [Abstract][Full Text] [Related]
35. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma.
Zou J; Chu S; Bao Q; Zhang Y
Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795
[TBL] [Abstract][Full Text] [Related]
36. A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Cao Y; Dai Z; Xie G; Liu G; Guo L; Zhang J
Exp Cell Res; 2023 Jul; 428(2):113628. PubMed ID: 37149080
[TBL] [Abstract][Full Text] [Related]
37. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
38. Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma.
Gao Q; Shi Y; Sun Y; Zhou S; Liu Z; Sun X; DI X
Oncol Res; 2023; 31(1):35-61. PubMed ID: 37303739
[TBL] [Abstract][Full Text] [Related]
39. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment.
He Y; Xiang J; Li Y; Huang W; Gu F; Wang Y; Chen R
Cancer Med; 2023 Jun; 12(11):12622-12638. PubMed ID: 37076985
[TBL] [Abstract][Full Text] [Related]
40. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
